As expected, the lesions in CUMS + siRNA group, and CUMS + PDTC group were significantly reduced compared with CUMS group, respectively (Fig 4B, both P < 0.05), indicating that inhibition of TLR4/NF-κB obviously attenuated CUMS-induced atherosclerosis. The gene discussed is NFKB1; the disease is atherosclerosis.